糖新药-话题@MedSci - 梅斯（MedSci）

#糖新药#

9篇内容 | 1079人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2055005, encodeId=16e020550054b, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=JAHA：两类降糖新药还有降压功效！北大人民医院纪立农等Meta分析称，通过减重而非降糖发挥此作用, objectType=article, longId=191700, objectId=9b30191e00ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b30191e00ae, replyNumber=0, likeNumber=86, createdTime=2020-12-05, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b30191e00ae, moduleTitle=JAHA：两类降糖新药还有降压功效！北大人民医院纪立农等Meta分析称，通过减重而非降糖发挥此作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9b30191e00ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2055004, encodeId=dc5c2055004a7, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=由根皮苷到坎格列净：来源于植物的神奇降糖新药, objectType=article, longId=179381, objectId=53ff1e9381fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ff1e9381fe, replyNumber=0, likeNumber=91, createdTime=2020-08-13, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ff1e9381fe, moduleTitle=由根皮苷到坎格列净：来源于植物的神奇降糖新药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=53ff1e9381fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2055003, encodeId=2d4e2055003c0, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=喜大普奔！降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国, objectType=article, longId=161211, objectId=849816121109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849816121109, replyNumber=0, likeNumber=97, createdTime=2019-09-28, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849816121109, moduleTitle=喜大普奔！降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=849816121109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2055002, encodeId=fd2f2055002c7, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=礼来降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国, objectType=article, longId=161199, objectId=4d8e16119952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8e16119952, replyNumber=0, likeNumber=87, createdTime=2019-12-20, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8e16119952, moduleTitle=礼来降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4d8e16119952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2055001, encodeId=a3582055001fe, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%, objectType=article, longId=150492, objectId=25fa15049273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25fa15049273, replyNumber=0, likeNumber=64, createdTime=2019-07-25, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25fa15049273, moduleTitle=Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25fa15049273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2055000, encodeId=65ff205500085, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=降糖药物“变天”：心血管科医生为降糖新药感到振奋, objectType=article, longId=114442, objectId=f502114442bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f502114442bc, replyNumber=0, likeNumber=83, createdTime=2018-05-16, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f502114442bc, moduleTitle=降糖药物“变天”：心血管科医生为降糖新药感到振奋, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f502114442bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054998, encodeId=280420549987e, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=礼来制药降糖新药Dulaglutide非劣效于利拉鲁肽（Liraglutide） (AWARD-6研究）, objectType=article, longId=31331, objectId=54b3313316b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b3313316b, replyNumber=0, likeNumber=84, createdTime=2015-01-19, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b3313316b, moduleTitle=礼来制药降糖新药Dulaglutide非劣效于利拉鲁肽（Liraglutide） (AWARD-6研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=54b3313316b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054999, encodeId=d4ed2054999cd, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance, objectType=article, longId=39710, objectId=b27f39e10a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b27f39e10a3, replyNumber=0, likeNumber=63, createdTime=2015-04-07, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b27f39e10a3, moduleTitle=礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b27f39e10a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054997, encodeId=1e88205499e85, content=<a href='/topic/show?id=8683e68224c' target=_blank style='color:#2F92EE;'>#糖新药#</a>, objectTitle=CHMP建议批准阿斯利康和百时美施贵宝降糖新药Xigduo, objectType=article, longId=27142, objectId=6f712e142a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f712e142a5, replyNumber=0, likeNumber=71, createdTime=2014-10-04, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f712e142a5, moduleTitle=CHMP建议批准阿斯利康和百时美施贵宝降糖新药Xigduo, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6f712e142a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖新药

2020-05-29

haouestc (审核中...)

前往app查看评论内容

#糖新药#

JAHA：两类降糖新药还有降压功效！北大人民医院纪立农等Meta分析称，通过减重而非降糖发挥此作用

2020-12-05

haouestc (审核中...)

前往app查看评论内容

#糖新药#

由根皮苷到坎格列净：来源于植物的神奇降糖新药

2020-08-13

haouestc (审核中...)

前往app查看评论内容

#糖新药#

喜大普奔！降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国

2019-09-28

haouestc (审核中...)

前往app查看评论内容

#糖新药#

礼来降糖新药GLP-1受体激动剂周制剂度易达®（度拉糖肽）正式获批进入中国

2019-12-20

haouestc (审核中...)

前往app查看评论内容

#糖新药#

Lancet：新型GIP/GLP-1R双靶点降糖新药II期数据惊艳，HbA1c下降达2.4%

2019-07-25

haouestc (审核中...)

前往app查看评论内容

#糖新药#

降糖药物“变天”：心血管科医生为降糖新药感到振奋

2018-05-16

haouestc (审核中...)

前往app查看评论内容

#糖新药#

礼来制药降糖新药Dulaglutide非劣效于利拉鲁肽（Liraglutide） (AWARD-6研究）

2015-01-19

haouestc (审核中...)

前往app查看评论内容

#糖新药#

礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance

2015-04-07

haouestc (审核中...)

前往app查看评论内容

#糖新药#

CHMP建议批准阿斯利康和百时美施贵宝降糖新药Xigduo

2014-10-04

科室
- - 订阅+
  - 更多科室
工具
服务